The Latest Breaking News from Tobacco

New Zealand’s smokefree law was hailed around the world for creating a smokefree generation that would have lifelong protection from smoking’s harms.

The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend

Massachusetts outlawed flavored tobacco. Now, just as criminal justice groups warned, a vape shop owner is serving time.

Shares fell as much 9% as it revealed a slight decline in US vape sales, which it has touted as the future of the smoking industry.

With Trump’s tariff strategy giving U.S. brands a competitive edge, Bank of America sees these two names as key beneficiaries.

Tobacco giant Philip Morris has significantly outperformed the broader market over the past year and analysts remain bullish on the stock’s prospects.

The market for consumer essentials and necessities is growing rapidly, thanks to the resilient demand and increasing sustainable practices, making consumer staples stocks ideal for investors following defensive investing. Amid this, robust consumer staples stocks PepsiCo (PEP), Philip Morris International (PM), and Kimberly-Clark (KMB) could be ideal buys for defensive…

Altria outperformed the broader market over the past year, yet Wall Street analysts remain cautious about the stock’s prospects.

Osaka gears up for Expo 2025 with a public smoking ban to enhance safety and cleanliness, aligning with Japan's declining tobacco use trend.

Biden's FDA pushed a prohibition that disproportionately targeted marginalized communities. Trump's reversal may mark a shift toward smarter drug policy.

The FDA has recently authorized the sale of Zyn nicotine pouches, marking a pivotal moment in tobacco harm reduction. As concerns about traditional smoking persist, nicotine pouches present a viable alternative for adult smokers. This approval underscores their potential public health benefits, despite challenges surrounding youth appeal.